Effects of percutaneous transluminal angioplasty on muscle BOLD-MRI in patients with peripheral arterial occlusive disease: preliminary results.
The purpose was to evaluate the effect of percutaneous transluminal angioplasty (PTA) of the superficial femoral artery (SFA) on the blood oxygenation level-dependent (BOLD) signal change in the calf musculature of patients with intermittent claudication. Ten patients (mean age, 63.4+/-11.6 years) with symptomatic peripheral arterial occlusive disease (PAOD) caused by SFA stenoses were investigated before and after PTA. Patients underwent BOLD-MRI 1 day before and 6 weeks after PTA. A T2*-weighted single-shot multi-echo echo-planar MR-imaging technique was applied. The BOLD measurements were acquired at mid-calf level during reactive hyperaemia at 1.5 T. This transient hyperperfusion of the muscle tissue was provoked by suprasystolic cuff compression. Key parameters describing the BOLD signal curve included maximum T2* (T2*(max)), time-to-peak to reach T2*(max) (TTP) and T2* end value (EV) after 600 s of hyperemia. Paired t-tests were applied for statistic comparison. Between baseline and post-PTA, T2*(max) increased from 11.1+/-3.6% to 12.3+/-3.8% (p=0.51), TTP decreased from 48.5+/-20.8 s to 35.3+/-11.6 s (p=0.11) and EV decreased from 6.1+/-6.4% to 5.0+/-4.2% (p=0.69). In conclusion, BOLD-MRI reveals changes of the key parameters T2*(max), TTP, and EV after successful PTA of the calf muscles during reactive hyperaemia.
Huegli
Rolf W
RW
Department of Radiology, Division of Interventional Radiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. rolf.huegli@ksbh.ch
Schulte
Anja-Carina
AC
Aschwanden
Markus
M
Thalhammer
Christoph
C
Kos
Sebastian
S
Jacob
Augustinus L
AL
Bilecen
Deniz
D
D000368:Aged; D015901:Angiography, Digital Subtraction / Q000379:methods; D000800:Angioplasty, Balloon / Q000379:methods*; D050197:Atherosclerosis / Q000175:diagnosis / Q000473:pathology*; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000473:pathology*; D010477:Perfusion; D016491:Peripheral Vascular Diseases / Q000175:diagnosis* / Q000473:pathology*; D012307:Risk Factors; D013997:Time Factors
Magn Reson Med. 1998 Oct;40(4):551-8
9771572
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5675-9
1608978
Circulation. 2006 Jun 27;113(25):2929-35
16785340
J Magn Reson Imaging. 1998 Sep-Oct;8(5):1106-13
9786149
Magn Reson Med. 2006 Feb;55(2):450-4
16342333
Magn Reson Med. 1996 Jan;35(1):62-9
8771023
Semin Musculoskelet Radiol. 2003 Dec;7(4):307-15
14735429
Neuroimage. 2004 Sep;23(1):148-55
15325361
Circulation. 1993 Feb;87(2):413-21
8425290
J Magn Reson Imaging. 1999 Jun;9(6):814-20
10373029
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
2124706
Cardiovasc Res. 1985 Aug;19(8):507-12
4042117
Clin Physiol. 1981 Jun;1(3):253-6
7199985
J Appl Physiol (1985). 2005 Jan;98(1):264-73
15333610
NMR Biomed. 2006 Nov;19(7):954-67
17075963
Magn Reson Med. 1998 Aug;40(2):243-8
9702706
Magn Reson Imaging. 1998 Sep;16(7):721-9
9811138
Radiology. 2006 Nov;241(2):477-84
16982813
J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296
10666287
Magn Reson Med. 1995 Oct;34(4):555-66
8524024
Magn Reson Med. 2003 Jun;49(6):1019-27
12768579
Vasc Med. 2006 Feb;11(1):29-33
16669410
Scand J Clin Lab Invest. 1980 Jun;40(4):361-9
6251535
J Am Coll Cardiol. 1997 Sep;30(3):664-9
9283523
Radiology. 2003 Mar;226(3):791-7
12601207
Diabetes Care. 2003 Dec;26(12):3357-8
14633834
Magn Reson Med. 2002 Oct;48(4):589-93
12353274
Atherosclerosis. 2004 Jan;172(1):95-105
14709362
Magn Reson Med. 2001 Mar;45(3):443-7
11241702